Reilly Financial Advisors’s Indaptus Therapeutics INDP Stock Holding History

Reilly Financial Advisors’s Portfolio INDP Stock Details INDP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	$0	Hold	2	–	–	﹤0.01%	1162
2021 Q3	$0	Buy	+2	New	+$577	﹤0.01%	980
2020 Q4	–	Sell	-2	Closed	-$1K	–	904
2020 Q3	$1K	Hold	2	–	–	﹤0.01%	799
2020 Q2	$1K	Hold	2	–	–	﹤0.01%	852
2020 Q1	$1K	Hold	2	–	–	﹤0.01%	838
2019 Q4	$3K	Hold	2	–	–	﹤0.01%	778
2019 Q3	$4K	Hold	2	–	–	﹤0.01%	767
2019 Q2	$22K	Hold	2	–	–	﹤0.01%	511
2019 Q1	$37K	Hold	2	–	–	﹤0.01%	401
2018 Q4	$38K	Buy	+2	New	+$27.3K	0.01%	374

Other funds holding INDP

SWP

Stratos Wealth Partners Beachwood, Ohio $8.8B AUM 21.82% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

IHL

Investment House LLC Redondo Beach, California $2.21B AUM 39.6% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

UCFA

United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return

Reilly Financial Advisors's INDP Position: Q4 2021 in Review

Reilly Financial Advisors held its Indaptus Therapeutics (INDP) position steady in Q4 2021 at 2 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #1162.

Reilly Financial Advisors first reported a position in INDP in Q4 2018 and has held it in 10 quarters since. The position peaked at $38K in Q4 2018. 14 funds tracked by Wall St. Rank hold INDP as of Q4 2021.

Reilly Financial Advisors held 2 shares of Indaptus Therapeutics worth $0 as of Q4 2021.
Reilly Financial Advisors left its Indaptus Therapeutics share count unchanged in Q4 2021.
Indaptus Therapeutics made up ﹤0.01% of Reilly Financial Advisors's portfolio in Q4 2021, its #1162 holding.
Reilly Financial Advisors first reported a position in Indaptus Therapeutics in Q4 2018 and has held it in 10 quarters since.
Reilly Financial Advisors's Indaptus Therapeutics position peaked at $38K in Q4 2018.
14 funds tracked by Wall St. Rank held Indaptus Therapeutics as of Q4 2021.

Based on Reilly Financial Advisors's 13F filing for Q4 2021, filed 25 Jan 2022.